menu
    • menu

    Company profile for GemVax & KAEL

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    GemVax group incorporated under the corporation philosophy of ‘Devotion to Healthy Life’ is engaged in new drug development and other various business with GemVax & KAEL established in 1998, Samsung Pharm, Enerzent and FEELingK. GemVax & KAEL has become a high-value added environmental company by succeeding industry-first domestic production of chemical filters and gas scrubbers in semiconductor and display industry and de...
    GemVax group incorporated under the corporation philosophy of ‘Devotion to Healthy Life’ is engaged in new drug development and other various business with GemVax & KAEL established in 1998, Samsung Pharm, Enerzent and FEELingK. GemVax & KAEL has become a high-value added environmental company by succeeding industry-first domestic production of chemical filters and gas scrubbers in semiconductor and display industry and developed the first-in-class immunotherapeutic drug RIAVAX™inj. as the 21st new drug developed by Korean pharmaceutical company.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GemVax & KAELkorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    58 Techno 11-ro, Yuseong-gu, Dajeon
    Telephone
    Telephone
    +82 042-931-6287
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.gemvax.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/gemvax-&-kael-co-ltd
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gemvax Announces Phase 2A Results For Progressive Supranuclear Palsy
    Gemvax Announces Phase 2A Results For Progressive Supranuclear Palsy

    29 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/gemvax-announces-topline-results-from-phase-2a-progressive-supranuclear-palsy-clinical-trial-at-neuro2024-302289880.html

    PR NEWSWIRE
    29 Oct 2024
    Share Share
    Complix and VIB Publish Pioneering Study on Cell-Penetrating Alphabodies
    Complix and VIB Publish Pioneering Study on Cell-Penetrating Alphabodies

    30 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/complix-and-vib-publish-pioneering-study-on-cell-penetrating-alphabodies-in-science-advances-301258629.html

    PRNEWSWIRE
    30 Mar 2021
    Share Share
    GemVax's highly promising Phase II Alzheimer's disease clinical trial results
    GemVax's highly promising Phase II Alzheimer's disease clinical trial results

    30 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/gemvaxs-highly-promising-phase-ii-alzheimers-disease-clinical-trial-results-targeting-telomerase-published-in-prestigious-alzheimers-research--therapy-journal-301258354.html

    PRNEWSWIRE
    30 Mar 2021
    Share Share
    GemVax & KAEL reports further positive data from GV1001 Ph II Alzheimer's trial 
    GemVax & KAEL reports further positive data from GV1001 Ph II Alzheimer's trial 

    23 Nov 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/gemvax--kael-reports-further-positive-data-from-gv1001-phase-ii-alzheimers-disease-trial-301178368.html

    PRNEWSWIRE
    23 Nov 2020
    Share Share
    GemVax & KAEL reports further positive data from GV1001 Phase II
    GemVax & KAEL reports further positive data from GV1001 Phase II

    23 Nov 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/gemvax--kael-reports-further-positive-data-from-gv1001-phase-ii-alzheimers-disease-trial-301178368.html

    PRNEWSWIRE
    23 Nov 2020
    Share Share
    GemVax Announces to apply for expanded access IND for GV1001
    GemVax Announces to apply for expanded access IND for GV1001

    06 Oct 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/promising-phase-ii-results-underpin-gemvax-decision-to-apply-for-expanded-access-ind-for-gv1001-in-alzheimers-disease-301146372.html

    PRNEWSWIRE
    06 Oct 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search